Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

West Pharmaceutical Services, Inc. (WST) had Cost of Goods Sold of $1.89B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$2.89B
Net Income	$492.70M
Cost of Goods Sold	$1.89B
Gross Profit	$998.50M
Operating Expenses	$2.32B
Operating Income	$569.90M
Non-Operating Income/Expense	$15.60M
Pre-Tax Income	$585.50M
Normalized Pre-Tax Income	$585.50M
Income after Taxes	$478.00M
Income from Continuous Operations	$492.70M
Consolidated Net Income/Loss	$492.70M
Normalized Income after Taxes	$478.00M
EBIT	$569.90M
EBITDA	$725.30M
Weighted-Average Shares Outstanding (Basic)	73.00M
Weighted-Average Shares Outstanding (Diluted)	73.70M
Earnings per Share (EPS) (Basic)	$6.75
Earnings per Share (EPS) (Diluted)	$6.69
Balance Sheet Financials
Current Assets	$1.54B
Property, Plant, and Equipment	$1.58B
Long-Term Assets	$2.11B
Total Assets	$3.64B
Current Liabilities	$550.40M
Long-Term Debt	$202.60M
Long-Term Liabilities	$410.70M
Total Liabilities	$961.10M
Common Equity	$2.68B
Tangible Shareholders Equity	$2.57B
Shareholders Equity	$2.68B
Common Shares Outstanding	72.30M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$653.40M
Cash Flow from Investing Activities	$-378.70M
Cash Flow from Financial Activities	$-622.60M
Beginning Cash	$853.90M
End Cash	$484.60M
Increase/Decrease in Cash	$-369.30M
Stock-Based Compensation	$18.70M
Common Stock Dividends Paid	$-59.10M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.79
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.07
Debt to Equity Ratio	0.08
Gross Margin	34.51%
Operating Margin	19.70%
EBIT Margin	19.70%
EBITDA Margin	25.07%
Pre-Tax Profit Margin	20.24%
Profit Margin	17.03%
Free Cash Flow	$276.40M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.79
Inventory Turnover	5.03
Receiveable Turnover	5.24
Days Sales in Receivables	69.70
Return on Equity	18.37%
Return on Tangible Equity	19.20%
Return on Assets	13.52%
Return on Investments	17.08%
Book Value Per Share	$37.10
Free Cash Flow per Share	$3.75
Operating Cash Flow per Share	$8.87

Data from Zacks Investment Research, Inc.